News Articles


Prognostic impact of COX-2 in lung cancer

COX-2 stroma.png

In a study performed by scientists at Uppsala University, in collaboration with Gothenburg University and the Human Protein Atlas project, the expression of cyclooxygenase-2 (COX-2) was evaluated in patients with non-small cell lung cancer (NSCLC).

To clarify previous inconsistences concerning the prognostic impact of COX-2 expression in NSCLC, the association between COX-2 transcript levels (encoded by the gene PTGS2) and overall survival in nine publicly available gene expression microarray data sets were evaluated as well as the in situ protein expression of COX-2 in tumor and stromal cells in two independent NSCLC cohorts...Read more


Upcoming Events


Protein A-Based purification of antibodies

January 8, 2018

Prof. Sophia Hober will present the latest advances regarding engineering of protein A, for Ca-mediated purification of antibodies. Her talk is scheduled on January 9, during one of the largest annual events focusing on protein science, the PepTalk conference.

High-Throughput Protein Production within the Swedish Human Protein Atlas

January 8, 2018 - January 12, 2018

Development of the Human Protein Atlas, protein production pipeline will be highlighted in the upcoming PepTalk conference in a talk given by PhD Hanna Tegel.